Search Results - "Russell, Heidi"

Asparaginase products in upfront acute lymphoblastic leukemia therapy: Value, location, and style by Russell, Heidi V.

Get full text

Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma by Louis, Chrystal U., Savoldo, Barbara, Dotti, Gianpietro, Pule, Martin, Yvon, Eric, Myers, G. Doug, Rossig, Claudia, Russell, Heidi V., Diouf, Oumar, Liu, Enli, Liu, Hao, Wu, Meng-Fen, Gee, Adrian P., Mei, Zhuyong, Rooney, Cliona M., Heslop, Helen E., Brenner, Malcolm K.

“…We generated MHC-independent chimeric antigen receptors (CARs) directed to the GD2 antigen expressed by neuroblastoma tumor cells and treated patients with…”
Get full text

Mental distress and health care use among survivors of adolescent and young adult cancer: A cross‐sectional analysis of the National Health Interview Survey by Kaul, Sapna, Avila, Jaqueline C., Mutambudzi, Miriam, Russell, Heidi, Kirchhoff, Anne C., Schwartz, Cindy L.

“…BACKGROUND The current study was conducted to examine the prevalence and correlates of mental distress among survivors of adolescent and young adult (AYA)…”
Get full text

Payer and race/ethnicity influence length and cost of childhood cancer hospitalizations by Whittle, Sarah B., Lopez, Michelle A., Russell, Heidi V.

“…Background Health disparities related to race, ethnicity, socioeconomic status, and insurance status impact quality, access, and health outcomes for children…”
Get full text

Parent-Reported Clinical Utility of Pediatric Genomic Sequencing by Smith, Hadley Stevens, Ferket, Bart S, Gelb, Bruce D, Hindorff, Lucia, Ferar, Kathleen D, Norton, Mary E, Sahin-Hodoglugil, Nuriye, Slavotinek, Anne, Lich, Kristen Hasmiller, Berg, Jonathan S, Russell, Heidi V

“…Genomic sequencing (GS) is increasingly used for diagnostic evaluation, yet follow-up care is not well understood. We assessed clinicians' recommendations…”
Get full text

Clinical Application of Genome and Exome Sequencing as a Diagnostic Tool for Pediatric Patients: a Scoping Review of the Literature by Smith, Hadley Stevens, Swint, J. Michael, Lalani, Seema R., Yamal, Jose-Miguel, de Oliveira Otto, Marcia C., Castellanos, Stephan, Taylor, Amy, Lee, Brendan H., Russell, Heidi V.

“…Availability of clinical genomic sequencing (CGS) has generated questions about the value of genome and exome sequencing as a diagnostic tool. Analysis of…”
Get full text

Rising drug cost impacts on cost‐effectiveness of 2 chemotherapy regimens for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group by Russell, Heidi V., Chi, Yueh‐Yun, Okcu, M. Fatih, Bernhardt, M. Brooke, Rodriguez‐Galindo, Carlos, Gupta, Abha A., Hawkins, Douglas S.

“…Background The Children's Oncology Group clinical trial for intermediate risk rhabdomyosarcoma randomized participants to a combination of vincristine,…”
Get full text

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma by Brenner, Malcolm K, Pule, Martin A, Savoldo, Barbara, Myers, G Doug, Rossig, Claudia, Russell, Heidi V, Dotti, Gianpietro, Huls, M Helen, Liu, Enli, Gee, Adrian P, Mei, Zhuyong, Yvon, Eric, Weiss, Heidi L, Liu, Hao, Rooney, Cliona M, Heslop, Helen E

“…The promise of engineered T cells for treating cancer has been mitigated by their poor persistence when transferred to patients. Pule et al . now show that…”
Get full text

US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER) by Phillips, Kathryn A., Trosman, Julia R., Douglas, Michael P., Gelb, Bruce D., Ferket, Bart S., Hindorff, Lucia A., Slavotinek, Anne M., Berg, Jonathan S., Russell, Heidi V., Devine, Beth, Greve, Veronica, Smith, Hadley Stevens

“…There is limited payer coverage for genome sequencing (GS) relative to exome sequencing (ES) in the U.S. Our objective was to assess payers’ considerations for…”
Get full text

Neuroblastoma of the Bone and Bone Marrow Without an Apparent Primary Site: Report of 4 Cases With Long-term Follow-up by Rainusso, Nino, Seghers, Victor, Egler, Rachel, Hicks, John, Russell, Heidi V

“…Children with neuroblastoma rarely present with metastatic disease without identifiable primary tumors. We describe the clinical and histopathologic…”
Get full text

Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis by Schuman, Ari D., Chapel, Alyssa C., You, Peng, Venkatramani, Rajkumar, Russell, Heidi V., Raol, Nikhila, Ongkasuwan, Julina

“…Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is a rare, costly condition linked to human papillomavirus. Standard of care is serial surgical…”
Get full text

Using the Delphi method to identify clinicians’ perceived importance of pediatric exome sequencing results by Stevens Smith, Hadley, Russell, Heidi V., Lee, Brendan H., Morain, Stephanie R.

“…Purpose Information obtained from clinical exome sequencing (ES) may impact clinical care or other aspects of a patient’s life. Little is known about…”
Get full text

Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells by Ara, Tasnim, Song, Liping, Shimada, Hiroyuki, Keshelava, Nino, Russell, Heidi V, Metelitsa, Leonid S, Groshen, Susan G, Seeger, Robert C, DeClerck, Yves A

“…Neuroblastoma, the second most common solid tumor in children, frequently metastasizes to the bone marrow and the bone. Neuroblastoma cells present in the bone…”
Get full text

Exome sequencing compared with standard genetic tests for critically ill infants with suspected genetic conditions by Smith, Hadley Stevens, Swint, John M., Lalani, Seema R., de Oliveira Otto, Marcia C., Yamal, Jose-Miguel, Russell, Heidi V., Lee, Brendan H.

“…Purpose As exome sequencing (ES) is increasingly used as a diagnostic tool, we aimed to compare ES with status quo genetic diagnostic workup for infants with…”
Get full text

Radiation Therapy to the Primary and Postinduction Chemotherapy MIBG-Avid Sites in High-Risk Neuroblastoma by Mazloom, Ali, MD, Louis, Chrystal U., MD, Nuchtern, Jed, MD, Kim, Eugene, MD, Russell, Heidi, MD, PhD, Allen-Rhoades, Wendy, MD, Krance, Robert, MD, Paulino, Arnold C., MD

“…Purpose Although it is generally accepted that consolidation therapy for neuroblastoma includes irradiation of the primary site and any remaining…”
Get full text

Is high‐risk neuroblastoma induction chemotherapy possible without G‐CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors by Whittle, Sarah B., Smith, Valeria, Silverstein, Allison, Parmeter, Margaret, Minard, Charles G., Bernhardt, M. Brooke, Zage, Peter E., Venkatramani, Rajkumar, Nuchtern, Jed G., Heczey, Andras, Russell, Heidi V., Shohet, Jason M., Foster, Jennifer H.

“…Background/Objectives Standard supportive care during induction therapy for high‐risk neuroblastoma (HR‐NBL) includes primary prophylactic granulocyte…”
Get full text

Factors Influencing Family Burden in Pediatric Hematology/Oncology Encounters by Abrams, Hannah R, Leeds, Hayden S, Russell, Heidi V, Hellsten, Melody B

“…Caring for a child with cancer or hematologic disease places unique stress on a family unit. Families' subjective experience of this care-related burden…”
Get full text

Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: A scoping review and recommended methods by Ferket, Bart S., Baldwin, Zach, Murali, Priyanka, Pai, Akila, Mittendorf, Kathleen F., Russell, Heidi V., Chen, Flavia, Lynch, Frances L., Lich, Kristen Hassmiller, Hindorff, Lucia A., Savich, Renate, Slavotinek, Anne, Smith, Hadley Stevens, Gelb, Bruce D., Veenstra, David L.

“…Methodological challenges have limited economic evaluations of genome sequencing (GS) and exome sequencing (ES). Our objective was to develop conceptual…”
Get full text

Using decision modeling to guide drug allocation during a shortage by Russell, Heidi V., Bernhardt, M. Brooke, Berg, Stacey

“…Background Drug shortages require clinical teams to decide how to allocate drugs in limited supply among their patients. Ethical frameworks are invaluable for…”
Get full text

Economic evaluation of pediatric cancer treatment: a systematic literature review by Russell, Heidi V, Panchal, Janki, Vonville, Helena, Franzini, Luisa, Swint, J Michael

“…Although there is a growing national focus on health care cost containment and accountability in resource utilization, childhood cancer therapy costs continue…”
Get full text